|Title:||Nucleoside phosphoramidate prodrugs|
|Abstract:||Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure: ##STR00001## Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.|
|Inventor(s):||Du; Jinfa (Redwood City, CA), Nagarathnam; Dhanapalan (Bethany, CT), Sofia; Michael Joseph (Doylestown, PA), Wang; Peiyuan (Totowa, NJ)|
|Assignee:||Gilead Pharmasset LLC (Foster City, CA)|
>Claims of U.S. Appl. No. 14/013,237 as amended Aug. 30, 2013. cited by applicant
U.S. Appl. No. 13/956,195, filed Jul. 31, 2013. cited by applicant .
Claims of U.S. Appl. No. 13/956,195 as amended Oct. 21, 2013. cited by applicant.